Zydus Cadila’s Vaccine Gets Emergency Use nod form DCGI

0
60
zydus cadila zycov-d vaccine
Reading Time: < 1 minute

Zydus Cadila’s three dose vaccine ZyCoV-D became sixth to get emergency use authorization from Drug Controller General of India (DCGA). It can be administered to anyone more than 12 years old.

ZyCoV-D is world’s first India’s indigenously developed DNA based needle-free vaccine for Covid-19.

Five others vaccines with emergency use approval are:

  1. Serum Institute’s Covishield
  2. Bharat Biotech’s Covaxin
  3. Russia’s Sputnik V,
  4. Moderna’s Vaccine
  5. Johnson and Johnson’s Vaccine

About ZyCoV-D

ZyCov-D is the world’s first DNA vaccine against infection with SARS-CoV-2. It is a “plasmid DNA” vaccine that uses a genetically engineered, non-replicating version of a type of DNA molecule known as a ‘plasmid’.

About Zydus Cadila

Cadila Healthcare is an Ahmedabad, Gujrat based multinational pharmaceutical company founded by Ramanbhai Patel in 1952. Zydus Pharmaceuticals (USA) Inc. is the US generic drug division of much larger company Zydus Cadila Healthcare. It has presence in more than 50 countries.

LEAVE A REPLY

Please enter your comment!
Please enter your name here